Johnson & Johnson’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Johnson & Johnson’s Portfolio SWAV Stock Details SWAV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-166,812	Closed	-$54.3M	–	25
2024 Q1	$54.3M	Hold	166,812	–	–	1.23%	5
2023 Q4	$31.8M	Buy	+166,812	New	+$31.5M	0.72%	8

Other funds holding SWAV

Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

UWS

Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Johnson & Johnson's SWAV Position: Q2 2024 in Review

Johnson & Johnson sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 166,812 shares — an estimated $54.3M sold.

Johnson & Johnson first reported a position in SWAV in Q4 2023 and held it in 2 quarters. The position peaked at $54.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

Johnson & Johnson reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Johnson & Johnson sold 166,812 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $54.3M.
Johnson & Johnson first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
Johnson & Johnson's Shockwave Medical, Inc. Common Stock position peaked at $54.3M in Q1 2024.
7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Johnson & Johnson's 13F filing for Q2 2024, filed 9 Aug 2024.